IPO

The tech firm's massive capital raise via a unique offering aims to bolster its dual-engine model amid stock volatility and significant shareholder dilution.

RenX Enterprises touts massive growth after a reverse split, but a closer look reveals dilution risks, a heavy debt load, and a paid promotional campaign.

With a fresh Nasdaq listing and $57.2M in funding, Satellos is advancing a novel muscle-regenerating drug for Duchenne into pivotal pediatric trials.

Neutech Group builds on its education, healthcare, and wellness strategy, but a closer look at its 2025 financials reveals a more complex picture.

The digital infrastructure firm secured new funding for expansion, but a steep discount in its offering has rattled investors and sent its share price plunging.

The pharma firm hit pause on a crucial reverse stock split needed to keep its Nasdaq listing, citing "timing considerations" and raising investor questions.

The advanced optics maker announced a stock offering to fund operations as it navigates record revenue growth alongside plummeting profitability.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.

An activist investor and top proxy advisor ISS are urging ProCap Financial shareholders to reject a controversial AI merger, citing conflicts and dilution.

A Florida firm says its 15-year study proves 'Hypergrowth Stocks' are a unique asset class. But can a 40% growth metric truly redefine investing?

An ambitious plan to democratize wealth for small businesses, backed by prominent investors, confronts significant SEC hurdles and legislative dependencies.

As OpenAI shelves its costly Sora video project, smaller firms like ReelTime tout a new path: efficiency over brute force. Is this the future of AI video?

A new deal with a top European insurer validates Global AI's advanced platform in a high-stakes market, but can its financials keep pace with its tech?

Bitmedia is expanding beyond Web3, leveraging its battle-hardened ad tech to court high-value industries like finance and iGaming. Is this the future?

Renowned cardiac surgeon Dr. Robert C. Robbins brings his immense credibility to Linear Health Sciences, aiming to revolutionize patient care with a novel device.

The Fortune 50 firm is expanding into complex structured finance, aiming to unlock liquidity in non-traditional assets under veteran Rob Sannicandro.

A record $606.5M net income, fueled by a major divestment, funds a $200M dividend and a strategic merger creating a global IT powerhouse.

The Royal Canadian Mint will issue a special glow-in-the-dark two-dollar coin to celebrate 50 years of the iconic CN Tower, sparking collector excitement.

GlobalTech Corporation's move to the OTCQB market is more than a formality; it's a calculated step to boost transparency and fuel its AI-driven Nasdaq ambition.

A new auto marketplace is betting it can disrupt giants like CarGurus by eliminating upfront dealer fees and capturing buyers priced out of the new car market.